Diversity and prevalence of type VI secretion system effectors in clinical Pseudomonas aeruginosa isolates
Pseudomonas aeruginosa is an opportunistic pathogen and a major driver of morbidity and mortality in people with Cystic Fibrosis (CF). The Type VI secretion system (T6SS) is a molecular nanomachine that translocates effectors across the bacterial membrane into target cells or the extracellular envir...
Main Authors: | Luca A. Robinson, Alice C. Z. Collins, Ronan A. Murphy, Jane C. Davies, Luke P. Allsopp |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2022.1042505/full |
Similar Items
-
Acquisition of T6SS Effector TseL Contributes to the Emerging of Novel Epidemic Strains of Pseudomonas aeruginosa
by: Anmin Ren, et al.
Published: (2023-02-01) -
Structure-Based Prototype Peptides Targeting the Pseudomonas aeruginosa Type VI Secretion System Effector as a Novel Antibacterial Strategy
by: Xiaopan Gao, et al.
Published: (2017-09-01) -
The Role of Pseudomonas aeruginosa ExoY in an Acute Mouse Lung Infection Model
by: Christina Kloth, et al.
Published: (2018-05-01) -
A self-assembling split Nano luciferase-based assay for investigating Pseudomonas syringae effector secretion
by: Pei Miao, et al.
Published: (2024-02-01) -
Pseudomonas aeruginosa Quorum-Sensing and Type VI Secretion System Can Direct Interspecific Coexistence During Evolution
by: Kelei Zhao, et al.
Published: (2018-10-01)